A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent Asthma

NCT00507130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: MEDI528 0.3 mg/kg
BIOLOGICAL: MEDI528 1 mg/kg
BIOLOGICAL: MEDI528 3 mg/kg
OTHER: PLACEBO

Sponsor

MedImmune LLC